Leadership

Craig M. Kessler, MD, MACP

kessler

Professor of Medicine and Pathology, Georgetown University Medical Center

Director of Division of Coagulation in the Department of Laboratory Medicine

Directory of Therapeutic Cellular Apheresis Unit Director of the Comprehensive Hemophilia and Thrombophilia Treatment Center

Dr. Craig Kessler is Professor of Medicine and Pathology and attending physician in the Division of Hematology-Oncology at Georgetown University Medical Center in Washington, D.C., USA. He also serves as the Director of the Division of Coagulation in the Department of Laboratory Medicine and is the Director of the Therapeutic and Cellular Apheresis Unit. With over 40 years experience in designing, participating in, and analyzing clinical research trials in all areas of malignant and non-malignant hematology, Dr Kessler earned his medical degree from Tulane University School of Medicine and was elected to Alpha Omega Alpha. He completed his residency in Internal Medicine at the Ochsner Foundation Clinic in New Orleans, LA, where he also served as Chief Medical Resident, before moving to Baltimore, Maryland, to complete a Fellowship in Special Hematology at Johns Hopkins Hospital.

His first faculty position was in the Division of Clinical Pathology and Special Coagulation at the National Institutes of Health in Bethesda, Maryland, and, subsequently, he joined the faculty at the George Washington University Medical Center in Washington, D.C., where he became tenured Professor of Medicine, Chief of the Adult Component of the Washington Area Comprehensive Center for Hemophilia and Thrombosis Care, and Chief of the Division of Hematology-Oncology. In 1997 he joined the faculty at Georgetown University Medical Center as Professor of Medicine and Pathology in the Lombardi Comprehensive Cancer Center. He maintained leadership of the Hemophilia and Thrombosis programs and was Chief of the Division of Hematology-Oncology until 2007. He is the recipient of multiple prestigious awards, including the Kenneth Brinkhous Award in hemophilia research and the National Hemophilia Foundation Physician of the Year award; he has been repeatedly listed in The Best Doctors in America (from 1996 to present).

Dr. Kessler belongs to a number of professional societies, including the American Society of Hematology, the International Society on Thrombosis and Haemostasis, the World Federation of Hemophilia, and is a former president of the Hemostasis and Thrombosis Research Society of North America (HTRS). He sits on multiple medical and scientific advisory boards, and is Vice-President of the World Hemophilia Alliance. He serves on numerous industry, NIH, and CDC sponsored research study sections, DSMBs, and advisory boards. His areas of research lie in the area of basic and applied coagulation for the diagnosis and therapy of hypercoagulable states and the treatment of hereditary and acquired bleeding disorders. He has been particularly interested in the hypercoagulability of cancer and myeloproliferative neoplasms.

He is also Co-Editor of the journal Haemophilia and former Co-editor of the Seminars in Thrombosis and Hemostasis. Dr. Kessler has published over 200 peer reviewed articles, books and book chapters in the field of bleeding disorders and their treatment, including Co-editor of Consultative Hemostasis and Thrombosis, a very popular textbook on applied clinical coagulation. He has been elected to Mastership in the American College of Physicians and is currently Chair of the Medical and Scientific Advisory Council for the National Hemophilia Foundation.

Contact:
Phone: +1 202-687-8676

Publications

Care models in the management of haemophilia: a systematic review.


Yeung CH, Santesso N, Pai M, Kessler C, Key NS, Makris M, Navarro-Ruan T, Soucie JM, Schünemann HJ, Iorio A.

NHF-McMaster Guideline on Care Models for Haemophilia Management.


Pai M1, Key NS, Skinner M, Curtis R, Feinstein M, Kessler C, Lane SJ, Makris M, Riker E, Santesso N, Soucie JM, Yeung CH, Iorio A, Schünemann HJ.

Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation.


Kittelson JM, Steg PG, Halperin JL, Goldenberg NA, Schulman S, Spyropoulos AC, Kessler CM, Turpie AG, Cutler NR, Hiatt WR; Antithrombotic Trials Leadership and Steering (ATLAS) Group.

D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment.


Kearon C, Parpia S, Spencer FA, Baglin T, Stevens SM, Bauer KA, Lentz SR, Kessler CM, Douketis JD, Moll S, Kaatz S, Schulman S, Connors JM5, Ginsberg JS, Spadafora L, Liaw PC, Weitz JI, Julian JA.

For additional research publications please visit: https://www.researchgate.net/researcher/2051416645_Craig_M_Kessler